Zyprexa

When the government approves them, Health Ministry Director-General Avi Yisrael will issue orders to the health funds to provide them immediately to qualified patients, but there will be no retroactive coverage, even though the expanded basket should have been approved before January 1.

Israel Medical Association chairman Dr.

Yoram Blachar, a member of the public committee, said that the committee included "the most vital drugs for saving and extending life and preventing suffering.

A failure to include them would not allow the required level of medical care." He added that there remained a long list of other important drugs outside the basket, such as Avastin for colon cancer.PrintE-mailSubscribeHEALTH[ more » ]Health council urges NIS 466m.

expansion of servicesAnalysis: Health issues, portfolio are finally 'sexy'Who cares for the caregivers?

The price of health?

Ashkenazim and dystoniaAdvertisement JPost Sites:JPost Store · JPost Travel · Dating · America's Voices · JPost Français · The Jerusalem ReportSponsored Links:Find a Lawyer · Car Hire · Car Donations · Donate Car · Donate Vehicle · Fundraisers&Fundraising Ideas · Web Hosting · Israeli Poster Center · Upholstery fabric · Web Hosting Providers · Discount fabric · Make Money Online · Shopping · Fabri...

Moreover, prasugrel needs to show that it is superior to Plavix with an "immaterial increase" in bleeding risk.

Plavix is marketed jointly by Bristol-Myers Squibb (nyse: BMY - news - people ) and Sanofi-Aventis.Risinger trimmed 2006 and 2007 earnings-per-share estimates for Eli Lilly to $3.14 and $3.39, respectively, from $3.15 and $3.41.

More On This Topic Companies: MER LLY -% String xsl=(String) application.getAttribute(com.forbes.cms.Constants.XSL_REP_KEY)+"/story_body_html_trans.xsl"; final TransformerFactory tFactory = TransformerFactory.newInstance(); final Transformer transformer = tFactory.newTransformer(new StreamSource(xsl)); final ByteArrayOutputStream bao = new ByteArrayOutputStream(); byte[] bytes = transformedStoryStr.getBytes(); ByteArrayInputStream input=new ByteArrayInputStream(bytes); InputStream myInput=(InputStream)input; try{ transformer.transform(new StreamSource(myInput), new StreamResult(bao)); }catch (Exception e){ e.printStackTrace(); } transformedStoryStr=bao.toString(); // System.out.println(transformedStoryStr); transformedStoryStr=transformedStoryStr.replaceAll("&","&"); // transformedS...

"In our view, slowing growth trends do not support Lilly's premium valuation," Moskowitz stated.

The stock has rallied strongly since late last year.

Separately, Merrill Lynch's David Risinger downgraded Lilly to neutral from buy, citing difficulties with Cymbalta, the company's antidepressant medication.

"The trigger for our downgrade is that Cymbalta is struggling to gain prescription share despite [the] company's new promotional efforts," Risinger said.

Risinger went on to say that analyst projections for the company's long-term growth likely are too optimistic.

-Russ Britt; 415-439-6456; AskNewswires@dowjones.com Copyright (c) 2006 Dow Jones & Company, Inc.

Eli Lilly | detailed quote - chart - all headlines - add to watchlist previous 9:40am Eli Lilly downgraded to "underperform" Friedman,Billings,Ramsey &Co 8:57am Merrill Lynch, Friedman Billings Downgrade Lilly >LLY 03/27/06 Eli Lilly "neutral" Prudential Financial Copyright © 2002 - 2006 newratings.com, a Joint Venture of New Ratings Inc.

and aktiencheck.de AG Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using Standard&Poor's ComStock Inc.

and others.

Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.

All content copyright newratings.com.

All ...